Filing Flows › Elite Pharmaceuticals (ELTP) › Q1 FY27
Elite Pharmaceuticals (ELTP) Q1 FY27 earnings results (first quarter fiscal 2027)
10-Q filed Aug 13, 2026
Elite Pharmaceuticals (ELTP) reported revenue of $32.4M for the first quarter fiscal 2027 (Q1 FY27), -20% from a year earlier and -21% from the quarter before. Operating margin was 23.3%, net earnings $5.9M (18.3% of revenue).
Elite Pharmaceuticals, Q1 FY27: revenue $32.4M (-20% year over year), operating margin 23.3%, net earnings $5.9M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
| Q1 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32.4M | -21% | -20% |
| Gross profit | $13.5M | -35% | -50% |
| Operating profit | $7.5M | -26% | -65% |
| Net earnings | $5.9M | -68% | — |
| Operating cash flow | $10.1M | +10% | -32% |
| Free cash flow | $9.3M | +6% | -36% |
What changed
Revenue was $32.4M in Q1 FY27, down 20% year over year and down 21% from the previous quarter. Direct Sales to Wholesalers was the largest line at 51% of revenue. Indirect Sales to Wholesalers lost $5.0M year over year (down 24%), 64% of the total change.
Gross margin was 41.7%, down 26.0 points from Q1 FY26. Operating profit was $7.5M, a 23.3% margin (down 30.7 points year over year). Operating expenses grew 8% against a revenue fall of 20%. The fastest-growing cost line was Research & development (+21%). Net earnings were $5.9M. The effective tax rate was 23.4%.
Operating cash flow was $10.1M (down 32% year over year), 170% of net earnings. Non-cash charges added back $253K of depreciation and $28K of share-based compensation. Working capital and other items added $3.9M. Capital expenditures of $809K left free cash flow of $9.3M.
Questions
What was Elite Pharmaceuticals' revenue in the first quarter fiscal 2027?
Elite Pharmaceuticals (ELTP) reported revenue of $32.4M for the first quarter fiscal 2027 (Q1 FY27), -20% from a year earlier and -21% from the quarter before.
Was Elite Pharmaceuticals profitable in the first quarter fiscal 2027?
Operating profit was $7.5M (23.3% of revenue) and net earnings $5.9M.